According to the World Health Organization (WHO), 150,000 children with HIV under 15 years of age died of opportunistic infections in low-to-middle income countries in 2014 alone. But a study recently published in the journal of Clinical Infectious Diseases suggests that not only were many of these infections and deaths potentially preventable had the children received antiretroviral therapy (ART) to support their depleted immune systems, but doing so in future would result in annual savings of close to USD$ 18 million per year for health organizations around the world because they would reduce the costs of treating the diseases the children develop.
↧